• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[嗜铬细胞瘤/副神经节瘤患者临床特征与病理特征的关系]

[The relationship between clinical characteristics and pathological features in patients with pheochromocytomas/paragangliomas].

作者信息

Zhou Y, Zhang W Q, Chen Y H, Cui Y Y, Wang Y, Li T Y, Chang X Y, Tong A L

机构信息

Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China Graduate School, Hebei North University, Zhangjiakou 075000, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2024 Jul 23;104(28):2613-2618. doi: 10.3760/cma.j.cn112137-20231218-01404.

DOI:10.3760/cma.j.cn112137-20231218-01404
PMID:39019817
Abstract

To explore the correlation between clinical characteristics and pathological features in patients with pheochromocytoma/paraganglioma (PPGLs). A case series study. A retrospective analysis was conducted on patients with single and primary PPGLs after postoperative pathological diagnosis who were admitted to Peking Union Medical College Hospital between January 2019 and December 2022. The patients were divided into the Ki-67<3% group and the Ki-67≥3% group with Ki-67 proliferation index of 3% as the threshold. The relationship between clinical and pathological characteristics of PPGLs was analyzed. A total of 399 PPGLs patients were included, with 177 males and 222 females, aged [(, )] 45.0(35.5, 53.0) years. Among them, 226 (56.6%) cases originated from the adrenal gland, while 104 cases (26.1%) from the retroperitoneum. 20.9% (27/129) of the patients were found to harbor germline mutations of susceptibility genes, with SDHB mutations being the most common (10.1%, 13/129). The Ki-67 staining was performed on 302 cases, with a Ki-67 proliferation index [(, )] of 2.0% (1.0%, 3.0%). There were 194 cases in Ki-67<3% group and 108 cases in Ki-67≥3% group. Compared with the patients in Ki-67<3% group, the age of onset in Ki-67≥3% group was younger (=0.029). Compared with the patients with paragangliomas without SDHB or Cluster 1A-related gene mutations, positive I-meta-iodobenzylguanidine (I-MIBG) imaging or negative O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry staining, those with SDHB or Cluster 1A-related gene mutations, negative I-MIBG imaging or positive MGMT immunohistochemistry staining had a higher Ki-67 index (all <0.05). Compared with adrenal pheochromocytoma, retroperitoneal paragangliomas had a higher proportion of SDHB mutations and a higher proportion of normetanephrine (NMN) secretory types (all <0.05). Compared with adrenal pheochromocytoma, the maximum diameter of head and neck paraganglioma tumors was smaller [3.0 (1.9, 3.8) cm vs 4.7 (3.4, 6.4) cm, <0.001] and the proportion of Ki-67≥3% was higher (61.3% vs 33.8%, =0.007). PPGLs patients with earlier onset age, SDHB or Cluster 1A-related gene mutations, negative I-MIBG imaging, or positive MGMT immunohistochemistry staining tend to have a higher Ki-67 index. Head and neck tumors, though smaller, exhibit a higher proliferation potential.

摘要

探讨嗜铬细胞瘤/副神经节瘤(PPGLs)患者临床特征与病理特征之间的相关性。一项病例系列研究。对2019年1月至2022年12月在北京协和医院住院、术后经病理诊断为单发原发性PPGLs的患者进行回顾性分析。以Ki-67增殖指数3%为界值,将患者分为Ki-67<3%组和Ki-67≥3%组。分析PPGLs临床与病理特征之间的关系。共纳入399例PPGLs患者,其中男性177例,女性222例,年龄为[(, )]45.0(35.5,53.0)岁。其中,226例(56.6%)起源于肾上腺,104例(26.1%)起源于腹膜后。20.9%(27/129)的患者被发现携带易感基因的胚系突变,其中SDHB突变最为常见(10.

相似文献

1
[The relationship between clinical characteristics and pathological features in patients with pheochromocytomas/paragangliomas].[嗜铬细胞瘤/副神经节瘤患者临床特征与病理特征的关系]
Zhonghua Yi Xue Za Zhi. 2024 Jul 23;104(28):2613-2618. doi: 10.3760/cma.j.cn112137-20231218-01404.
2
Development and internal validation of a novel predictive model for mutations in pheochromocytomas and retroperitoneal paragangliomas.开发并内部验证一种用于预测嗜铬细胞瘤和腹膜后副神经节瘤中突变的新型预测模型。
Front Endocrinol (Lausanne). 2023 Dec 21;14:1285631. doi: 10.3389/fendo.2023.1285631. eCollection 2023.
3
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.SDHB突变与转移性嗜铬细胞瘤或副神经节瘤患者对替莫唑胺的反应相关。
Int J Cancer. 2014 Dec 1;135(11):2711-20. doi: 10.1002/ijc.28913. Epub 2014 May 5.
4
Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations.SDHB 突变相关嗜铬细胞瘤/副神经节瘤中原钙黏蛋白 PCDHGC3 的表观遗传失调。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5673-5692. doi: 10.1210/jc.2018-01471.
5
Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.半定量¹²³I-间碘苄胍闪烁扫描术鉴别嗜铬细胞瘤和副神经节瘤与生理性肾上腺摄取及其与儿茶酚胺转运体基因型依赖性表达的相关性
J Nucl Med. 2015 Jun;56(6):839-46. doi: 10.2967/jnumed.115.154815. Epub 2015 Apr 16.
6
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.一种用于检测携带种系SDHB、SDHC或SDHD基因突变的副神经节瘤和嗜铬细胞瘤患者的免疫组织化学方法:一项回顾性和前瞻性分析。
Lancet Oncol. 2009 Aug;10(8):764-71. doi: 10.1016/S1470-2045(09)70164-0. Epub 2009 Jul 1.
7
Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.与SDHB和SDHD基因突变相关的副神经节瘤综合征的独特临床特征。
JAMA. 2004 Aug 25;292(8):943-51. doi: 10.1001/jama.292.8.943.
8
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.免疫组织化学检测 SDHB 可用于对嗜铬细胞瘤-副神经节瘤综合征中的 SDHB、SDHC 和 SDHD 进行基因检测。
Hum Pathol. 2010 Jun;41(6):805-14. doi: 10.1016/j.humpath.2009.12.005. Epub 2010 Mar 17.
9
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.转移性嗜铬细胞瘤和副神经节瘤:生长抑素受体 2 的表达、遗传学和治疗反应。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2676-2685. doi: 10.1210/clinem/dgad166.
10
Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.韩国散发性嗜铬细胞瘤/副神经节瘤患者的胚系突变及基因型-表型相关性
Clin Genet. 2014 Nov;86(5):482-6. doi: 10.1111/cge.12304. Epub 2013 Nov 15.